Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail



Committee NameHealthcare Infection Control Practices Advisory CommitteeAgency NameDepartment of Health and Human Services
Fiscal Year2019Committee Number179
Original Establishment Date1/19/1991Committee StatusChartered
Actual Termination Date Committee URL
New Committee This FYNoPresidential Appointments*No
Terminated This FYNoMax Number of Members*44
Current Charter Date1/19/2019Designated Fed Officer Position Title*Deputy Director, DHQP
Date Of Renewal Charter1/19/2021Designated Federal Officer Prefix
Projected Termination Date Designated Federal Officer First Name*Michael
Exempt From Renewal*NoDesignated Federal Officer Middle Name
Specific Termination AuthorityDesignated Federal Officer Last Name*Bell
Establishment Authority*Authorized by LawDesignated Federal Officer SuffixM.D.
Specific Establishment Authority*42 U.S.C. 217aDesignated Federal Officer Phone*404-639-6490
Effective Date Of Authority*11/17/1962Designated Federal Officer Fax*(404) 639-3039
Exempt From EO 13875 Discretionary CmteNot ApplicableDesignated Federal Officer Email*
Committee Type*Continuing
Committee Function*Scientific Technical Program Advisory Board


Agency Recommendation*Continue
Legislation to Terminate RequiredNot Applicable
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*The Committee accomplishes its purpose by: 1) informing the development of CDC evidence-based guidelines for the prevention of healthcare-associated infections; 2) providing infection prevention and control guidance to address new or changing infectious disease threats such as pandemic influenza or antimicrobial (antibiotic) resistant pathogens; and 3) providing input into national surveillance efforts. During fiscal year 2019, the committee continued to provide input into the draft CDC guideline: the Guideline for Infection Control in Healthcare Personnel, and the Guideline for Infection Prevention in Neonatal Intensive Care Unit Patients. Additionally, the Committee provided a recommendation on NHSN Clostridioides difficile outcomes. The committee also provided input on antimicrobial use and resistance measures and antimicrobial stewardship efforts. The committee provided input on guideline methodology including both the way recommendations are formulated, and the categorization scheme for recommendations. The committee also provided input on targeted assessments for infection control efforts, and infection control related to medical devices including improving facility practices for endoscope reprocessing, heater cooler devices and associated outbreaks.
How is membership balanced?*The committee consists of 14 public members. In addition to considerations of balanced racial and ethnic groups, gender, and geographic representation, to be effective the committee must also be balanced by depth of experience (e.g., newer to the field vs. senior-level) and perspective (e.g., national, state, local). Furthermore, the committee must maintain a balance of expertise that is dependent upon the planned work of the committee. The committee’s membership represents expertise from the fields of infectious diseases, healthcare-associated infection prevention, healthcare epidemiology, surgery, public health, nursing, and related fields.
How frequent & relevant are cmte mtgs?*In fiscal year 2019 the Committee met in person two times and via teleconference once. Continued operation of the committee in fiscal year 2019 and beyond is required for the ongoing development, dissemination, and evaluation of CDC's infection control guidelines to prevent healthcare-associated infections and related adverse events, prevent the emergence of antimicrobial-resistant microorganisms, and improve quality of care across the spectrum of healthcare delivery. The committee provides critical guidance to CDC regarding these issues and as needed provides input on related issues such as surveillance and healthcare infection control practices for novel and emerging infectious diseases (e.g. Avian influenza, MERS, SARS, H1N1).
Why advice can't be obtained elsewhere?*CDC plays a unique role in healthcare-associated infection prevention activities in the U.S. and worldwide by developing and disseminating evidence-based infection control guidelines for preventing healthcare-associated infections and other adverse events in healthcare settings that are used to guide healthcare facilities in developing local protocols and procedures for infection control. Some recommendations become the standard for infection control when incorporated into other Agency and organizations standards (e.g., facility inspectors/surveyors such as those by Accreditation organizations or CMS). CDC actively investigates with State Health Departments and derives new evidence from outbreaks of healthcare-associated infections and CDC collaborates with other federal agencies and academic partners to apply those findings to update and improve prevention guidelines. CDC also manages and leads the National Healthcare Safety Network (NHSN), the nation’s most widely used healthcare-associated infection (HAI) tracking system. NHSN provides facilities, states, regions, and the nation with data from over 25,000 medical facilities to identify problem areas, measure progress of prevention efforts, and ultimately eliminate healthcare-associated infections. CDC uses input and advice from recognized experts described above to optimize guidelines and recommendations, assess trends, inform ongoing improvements to HAI monitoring and tracking, and review policy implications relevant to prevention of healthcare-associated infections.
Why close or partially close meetings?N/A
Recommendation RemarksSelwyn Rogers term start/end term dates updated. Term beginning and end dates were entered incorrectly. Dr. Rogers term ended on 12/31/2018.
Deborah Yokoe term end date updated. Term end date was entered incorrectly. Dr. Yokoe's term ended on 6/30/2019.
Hilary Babcock term end date updated. Extended 2-years as co-chair.
Christa Schorr is the new liaison representative for the Society of Critical Care Medicine and replaces Craig Coopersmith.
Pamela Truscott is the new liaison representative for the American Health Care Association and replaces Holly Harmon.
Dana Nguyen is the new liaison representative for the National Association of County and City Officials and replaces Jacqueline Lawler. Dorothy MacEachern is the alternate liaison representative.
Lisa Maragakis term end date updated. Extended 4-years as co-chair.
Holly Carpenter is the new liaison representative for the American Nurses Association and replaces Sharon Morgan.
Jan Patterson end date updated. Extended 2-years as a member.
Ronell Myburgh is the new liaison representative for DNV GL and replaces Linda Spaulding.
Karen deKay is the new liaison representative for the Association of periOperative Registered Nurses and replaces Amber Wood.
Deverick Anderson, Elaine Dekker, Michael Anne Preas, Nicholas Daniels, Mohamad Fakih, Judith Guzman-Cottrill, Michael Lin, and JoAnne Reifsnyder are new members.
Andrea Shane, Paul Conway, and Alan Kliger represent new liaison organizations to the committee.


Outcome Improvement To Health Or Safety*YesAction Reorganize Priorities*Yes
Outcome Trust In GovernmentYesAction Reallocate ResourcesNo
Outcome Major Policy ChangesYesAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchYesAction Proposed LegislationNo
Outcome Effective Grant MakingNoAction Approved Grants Or Other PaymentsNo
Outcome Improved Service DeliveryYesAction OtherNo
Outcome Increased Customer SatisfactionYesAction CommentNA
Outcome Implement Laws/Reg RequirementsNoGrants Review*No
Outcome OtherNoNumber Of Grants Reviewed0
Outcome CommentNANumber Of Grants Recommended0
Cost Savings*Unable to DetermineDollar Value Of Grants Recommended$0.00
Cost Savings CommentHealthcare associated infections cost the United States tens of millions of dollars annually. Implementation and adherence to CDC infection control guidelines that were informed from input from HICPAC potentially represent substantial cost savings for the nation and improved patient safety by reducing morbidity and mortality.Grants Review CommentThis committee does not engage in grant review.
Number Of Recommendations*503Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentInfection prevention recommendations address the very broad spectrum of healthcare quality, including specific procedures for safe surgery, current injection practices, personal and environmental hygiene, disinfection and sterilization of devices and equipment, correct management of patients undergoing intensive care and mechanical ventilation, insertion and maintenance of indwelling vascular catheters, and appropriate use of antimicrobial drugs. Although numerous, each recommendation contributes to successful patient care. CDC works with numerous partners (e.g., state, federal, professional assocations, industry) to develop user-friendly bundles and strategies to implement the specific recommendations.Access Agency WebsiteYes
% of Recs Fully Implemented*90.00%Access Committee WebsiteYes
% of Recs Fully Implemented CommentRecommendations to the agency have been implemented and are reflected in CDC guidelines and possible CDC Guideline recommendation updates.Access GSA FACA WebsiteYes
% of Recs Partially Implemented*10.00%Access PublicationsYes
% of Recs Partially Implemented CommentSometimes recommendations from the Committee are one of several internal and external inputs that CDC might use to inform decisions (e.g., federal register public comment period, other federal agency review, etc). Also, some recommendations will not be implemented until CDC Guidelines are published. CDC is currently working to refine, finalize, and publish the surveillance methods and guidelines that are informed by Committee's input.Access OtherYes
Agency Feedback*YesAccess CommentPublic Meetings
Agency Feedback CommentThe agency provides feedback to the committee through updates at regularly scheduled meetings and email communication to notify the HICPAC when action has been taken based on their recommendations.Narrative Description*CDC's mission is to promote health and quality of life by preventing and controlling disease, injury, and disability. The agency accomplishes its mission by working with partners to monitor health, develop and advocate sound public health policies, and implement prevention strategies. The Healthcare Infection Control Practices Advisory Committee supports CDC's mission by providing input into CDC's guidelines and recommendations for prevention of healthcare-associated infections (HAIs) as well as monitoring and tracking HAIs to improve patient safety in U.S. healthcare facilities.
Hide Section - COSTS


Payments to Non-Federal Members*$13,500.00Est Payments to Non-Fed Members Next FY*$38,500.00
Payments to Federal Members*$0.00Est. Payments to Fed Members Next FY*$0.00
Payments to Federal Staff*$117,451.00Estimated Payments to Federal Staff*$93,352.00
Payments to Consultants*$0.00Est. Payments to Consultants Next FY*$0.00
Travel Reimb. For Non-Federal Members*$21,750.00Est Travel Reimb Non-Fed Members nextFY*$33,935.00
Travel Reimb. For Federal Members*$0.00Est Travel Reimb For Fed Members*$0.00
Travel Reimb. For Federal Staff*$0.00Est. Travel Reimb to Fed Staff Next FY*$0.00
Travel Reimb. For Consultants*$1,933.00Est Travel Reimb to Consultants Next FY*$0.00
Other Costs$85,456.00Est. Other Costs Next FY*$86,328.00
Total Costs$240,090.00Est. Total Next FY*$252,115.00
Federal Staff Support (FTE)*1.05Est. Fed Staff Support Next FY*0.80
Hide Section - Custom Links

Custom Links

     Committee Level Reports               


To View all the members, meetings and advisory reports for this committee please click here


No Documents Found



Data from Previous Years

ActionCommittee System IDCommittee NameFiscal Year
 COM-034619Healthcare Infection Control Practices Advisory Committee2018
 COM-001889Healthcare Infection Control Practices Advisory Committee2017
 COM-002276Healthcare Infection Control Practices Advisory Committee2016
 COM-004088Healthcare Infection Control Practices Advisory Committee2015
 COM-004373Healthcare Infection Control Practices Advisory Committee2014
 COM-005835Healthcare Infection Control Practices Advisory Committee2013
 COM-006643Healthcare Infection Control Practices Advisory Committee2012
 COM-008077Healthcare Infection Control Practices Advisory Committee2011
 COM-009123Healthcare Infection Control Practices Advisory Committee2010
 COM-010241Healthcare Infection Control Practices Advisory Committee2009
 COM-010767Healthcare Infection Control Practices Advisory Committee2008
 COM-011917Healthcare Infection Control Practices Advisory Committee2007
 COM-012912Healthcare Infection Control Practices Advisory Committee2006
 COM-014070Healthcare Infection Control Practices Advisory Committee2005
 COM-014447Healthcare Infection Control Practices Advisory Committee2004
 COM-015837Healthcare Infection Control Practices Advisory Committee2003
 COM-016615Healthcare Infection Control Practices Advisory Committee2002
 COM-017603Healthcare Infection Control Practices Advisory Committee2001
 COM-018518Healthcare Infection Control Practices Advisory Committee2000
 COM-019604Healthcare Infection Control Practices Advisory Committee1999
 COM-020372Hospital Infection Control Practices Advisory Committee1998
 COM-021787Hospital Infection Control Practices Advisory Committee1997